KALARIS THERAPEUTICS, INC. Debt Securities, Available-for-sale, Current
KALARIS THERAPEUTICS, INC. (KLRS) had Debt Securities, Available-for-sale, Current of $19.93 million as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2026-03-17
- 2025-12-31: Debt Securities, Available-for-sale, Current $19.93M.
- 2025-09-30: Debt Securities, Available-for-sale, Current $34.61M.
- 2024-09-30: Debt Securities, Available-for-sale, Current $5.00M.
- 2024-06-30: Debt Securities, Available-for-sale, Current $24.87M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2025-12-31 | $19.93M 10-K · filed 2026-03-17 |
| 2025-09-30 | $34.61M 10-Q · filed 2025-11-12 |
| 2024-09-30 | $5.00M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $24.87M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $54.49M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $93.82M 10-K · filed 2025-03-07 |
| 2023-09-30 | $117.69M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $49.58M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $86.87M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $127.70M 10-K · filed 2024-03-15 |
| 2022-09-30 | $140.27M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $101.58M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $101.17M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $46.46M 10-K · filed 2023-02-15 |
| 2021-09-30 | $32.65M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $87.89M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $168.35M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $233.66M 10-K · filed 2022-02-10 |
| 2020-09-30 | $236.24M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $26.18M 10-Q · filed 2020-09-02 |
| 2020-03-31 | $168.30M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $64.99M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |